| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $44.2M | — | -7.6% |
| Cost of Revenue | $17.2M | — | +10.5% |
| Gross Profit | $27.0M | — | -16.3% |
| R&D Expense | $5.9M | — | +94.8% |
| SG&A Expense | $43.2M | — | +6.7% |
| Operating Income | -$22.1M | — | -96.6% |
| Pre-tax Income | -$27.6M | — | -55.1% |
| Income Tax | $25K | — | — |
| Net Income | -$27.6M | — | -55.2% |
| EPS (Basic) | -$0.74 | — | -48.0% |
| EPS (Diluted) | -$0.74 | — | -48.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $94.6M | +29.8% | +41.8% |
| Accounts Receivable | $101.3M | -8.7% | +31.4% |
| Inventory | $16.5M | +22.0% | +53.9% |
| Current Assets | $226.4M | +6.9% | +33.5% |
| Total Assets | $419.5M | +5.0% | +15.2% |
| Current Liabilities | $91.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.0M | — | -145.7% |
| Capital Expenditures | $194K | — | +14.1% |
| Investing Cash Flow | -$18.2M | — | -8486.3% |
| Financing Cash Flow | $48.9M | — | — |
| Free Cash Flow | -$9.2M | — | -147.1% |
| -51.1% |
| Long-term Debt | $300.0M | +20.0% | +16.8% |
| Total Liabilities | $391.2M | +12.6% | +27.0% |
| Stockholders' Equity | $28.7M | -45.3% | -49.1% |